Araştırma Çıktıları

Permanent URI for this communityhttps://hdl.handle.net/11443/931

Browse

Author: search.filters.author.Bahadir, Sinan

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Azathioprine as a Neuroprotective Agent in Experimental Traumatic Spinal Cord Injury
    (TURKISH NEUROSURGICAL SOC, 2021-01-01) Bahadir, Sinan; Onal, Mehmet Bulent; Narin, Firat; Basar, Ibrahim; Yigitkanli, Kazim; Bavbek, Murad; Ziyal, Mustafa Ibrahim
    AIM: To evaluate the protective effects of azathioprine, a macrophage-inhibiting agent, on secondary injury in spinal cord trauma. MATERIAL and METHODS: A total of 40 Wistar rats were randomly divided into 4 groups. All the animals had undergone T8-10 laminectomy. Except in group I (control), all the animals were exposed to spinal cord trauma at the T9 level. Animals in group II (trauma) received no treatment following trauma. Animals in group 3 (treatment) and group IV (vehicle) were given intraperitoneal azathioprine 4 mg/kg and saline 2 ml, respectively, 30 minutes after the trauma. Half of the animals in each group were sacrificed 24 hours after injury and specimens were used for biochemical and immunohistochemical evaluations. The rest of the animals were followed-up for 4 weeks in terms of neurological functions and were also sacrificed to perform the histopathological analysis. RESULTS: Significant decrease in apoptotic cells and improved neurological function were observed in the animals treated with azathioprine. Biological and immunohistochemical analysis also showed less oxidative stress in this group compared to those without treatment. CONCLUSION: Azathioprine, a potent macrophage-inhibiting agent, has been shown to decrease the extent of secondary injury following spinal cord trauma.
  • No Thumbnail Available
    Item
    Does the Application of Topical Intrawound Vancomycin Powder Affect Deep Surgical Site Infection and the Responsible Organisms after Spinal Surgery?: A Retrospective Case Series with a Historical Control Group
    (KOREAN SOC SPINE SURGERY, 2020-01-01) Adhikari, Prashant; Nabiyev, Vugar Nabi; Bahadir, Sinan; Ayhan, Selim; Yuksel, Selcen; Palaoglu, Selcuk; Acaroglu, Emre
    Study Design: Retrospective case series with a historical control group. Purpose: To compare the deep wound infection rates in patients undergoing spinal surgery with the application of topical intrawound vancomycin powder (TIVP) in the surgical site in addition to standard systemic prophylaxis with those in a matched historical cohort of patients for whom TIVP was not used. Overview of Literature: Surgical site infection (SSI) after spine surgery is debilitating and is responsible for a significant increase in the health care costs, hospital stay, and morbidities. Although the application of TIVP before surgical closure is a promising method for reducing the SSI rate after spine surgery, its use is controversial, and currently, research trials are focusing on identifying its safety, efficacy, and the potential patient population. Methods: A group of 88 patients who underwent posterior spinal surgery with TIVP administration (treatment group) was compared to a historical control group of 70 patients who had received only standard systemic intravenous prophylaxis (control group) for the analysis of deep SSI rate and the involved organisms. Results: The overall rate of deep SSIs was 2.5\% (4/158). All the SSIs were observed in patients who had posterior instrumentation and fusion for >= 3 levels. In the treatment group, the SSI rate was 3.4\% (3/88), and the bacteria isolated were Escherichia coli (n=2 ) and Pseudomonas aeruginosa (n=1). In the control group, the infection rate was 1.4\% (1/70), and the isolated bacteria were Morganella rnorganii and Staphylococcus epidermidis. No statistically significant association was found between the SSI rates of the treatment and control groups. Conclusions: Although the difference in the SSI rates was not statistically significant, the present results suggest that TIVP administration could not reduce the risk of deep SSIs after spinal surgery. Moreover, TIVP administration might also affect the underlying pathogens by increasing the propensity for gram-negative species.